Products |
Therapeutic Category |
CAS Number |
Pharmacopoeia |
DMF ( Open and Closed Part available) |
Dexamethasone Sodium Phosphate |
Gluco Corticosteroids |
2392-39-4 |
IP/BP/EP/USP |
Yes |
Betamethasone Sodium Phosphate |
Gluco Corticosteroids |
378-44-9 |
IP/BP/EP/USP |
Yes |
Prednisolone Sodium Phosphate |
Gluco Corticosteroids |
09-11-8056 |
IP/BP/EP/USP |
Yes |
Mometasone Furoate |
Gluco Corticosteroids |
83919-23-7 |
IP/BP/EP/USP |
Yes |
Betamethasone Dipropionate |
Gluco Corticosteroids |
5593-20-4 |
IP/BP/EP/USP |
|
Beclomethasone Dipropionate |
Gluco Corticosteroids |
‘5534-09-8 |
IP/BP/EP/JP/USP |
Yes |
Betamethasone 17 Valerate |
Gluco Corticosteroids |
2152-44-5 |
IP/BP/EP/JP/USP |
Yes |
Clobetasole 17 Propionate |
Gluco Corticosteroids |
25122-41-2 |
IP/BP/EP/USP |
Yes |
Triamcinolone Acetonide |
Gluco Corticosteroids |
76-25-5 |
BP/EP |
|
Diflucortolone Valerate |
Gluco Corticosteroids |
59198-70-8 |
BP |
|
Products will only be offered to the market where any process or products patents are not infringing. During the validity of the patents the research quantities for developing products for regulatory submission will only be offered to countries where such exemption exists (Hatch waxman Act / Bolar exemption). Recipient are requested to make their evaluation & determination as to the patent status prior to their use of information or materials in their respective jurisdiction.